These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3784450)

  • 1. Hematocrit as a risk factor for vascular disease.
    Kiesewetter H; Jung F; Lazar H; Roggenkamp HG; Leipnitz G; Kiehl R
    Klin Wochenschr; 1986 Oct; 64(19):974-8. PubMed ID: 3784450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
    Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Theoretical, experimental and clinical effects of variations in hematocrit during hemodilution].
    Duruble M; Martin JL; Duvelleroy M
    Ann Anesthesiol Fr; 1979; 20(9):805-14. PubMed ID: 45290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
    Ernst E; Kollar L; Matrai A
    Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodilution].
    Landgraf H
    Wien Med Wochenschr; 1986; 136 Spec No():36-40. PubMed ID: 3548090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
    Brehme S; Keysser G; Turowski A; Schmidt HH
    Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemorrheological changes in cerebrovascular disease].
    Fieschi C; Iadecola C
    Ric Clin Lab; 1983; 13 Suppl 3():189-93. PubMed ID: 6672995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isovolemic hemodilution as a functional therapy of decompensated arteriosclerotic stenoses of the femoral, cerebral and ophthalmic artery.
    Schmid-Schönbein H; Rieger H
    Ric Clin Lab; 1983; 13 Suppl 3():29-52. PubMed ID: 6673004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economics of blood products: the value of normovolemic hemodilution].
    Baron JF; Vicaut E; Duruble M; Duvelleroy M; Coriat P
    Rev Prat; 1988 Mar; 38(7):402-8. PubMed ID: 3353668
    [No Abstract]   [Full Text] [Related]  

  • 15. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemorrheological anomalies: an element of additional risk in arterial diseases].
    Mancini M; Postiglione A; Lamenza F; Patti L; Rubba P
    Ric Clin Lab; 1983; 13 Suppl 3():181-8. PubMed ID: 6672994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rheological effects of normovolemic hemodilution].
    Cozette P; Gaillard S; Rose E; Carnielo M
    Ann Anesthesiol Fr; 1979; 20(9):775-83. PubMed ID: 45288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood rheology and systemic oxygen transport.
    Brückner UB; Messmer K
    Biorheology; 1990; 27(6):903-12. PubMed ID: 2093398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute normovolemic hemodilution.
    Jobes DR; Gallagher J
    Int Anesthesiol Clin; 1982; 20(4):77-95. PubMed ID: 6757146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.